X-154534465-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001360016.2(G6PD):āc.517T>Cā(p.Phe173Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,098,041 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ā ).
Frequency
Consequence
NM_001360016.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
G6PD | NM_001360016.2 | c.517T>C | p.Phe173Leu | missense_variant | 6/13 | ENST00000393562.10 | NP_001346945.1 | |
G6PD | NM_000402.4 | c.607T>C | p.Phe203Leu | missense_variant | 6/13 | NP_000393.4 | ||
G6PD | NM_001042351.3 | c.517T>C | p.Phe173Leu | missense_variant | 6/13 | NP_001035810.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
G6PD | ENST00000393562.10 | c.517T>C | p.Phe173Leu | missense_variant | 6/13 | 1 | NM_001360016.2 | ENSP00000377192 | P4 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 182837Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67403
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098041Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 363425
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Anemia, nonspherocytic hemolytic, due to G6PD deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 11, 2022 | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt G6PD protein function. ClinVar contains an entry for this variant (Variation ID: 10407). This variant is also known as G6PD NanKang. This missense change has been observed in individual(s) with G6PD deficiency (PMID: 16329560, 20582980, 30045279). This variant is present in population databases (rs137852343, gnomAD 0.02%). This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 173 of the G6PD protein (p.Phe173Leu). - |
Pathogenic, criteria provided, single submitter | curation | Dunham Lab, University of Washington | Aug 12, 2022 | Variant found in unrelated hemizygotes with deficiency, some with jaundice (PS4_M, PP4). Decreased activity in red blood cells (5-33%) (PS3). Below expected carrier frequency in gnomAD (PM2). Reported as pathogenic by Invitae (PP5). Post_P 0.994 (odds of pathogenicity 1517, Prior_P 0.1). - |
Malaria, susceptibility to Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 26, 2023 | - - |
G6PD NANKANG Other:1
other, no assertion criteria provided | literature only | OMIM | Apr 18, 2013 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at